domenica, 3 maggio 2026

Notizie AIOM – anno XV

26 Ottobre 2017

Web-app

Una nuova web-app gratuita, in otto lingue, per computer, tablet e smartphone sul tumore del pancreas è disponibile sul sito del Corriere della Sera in collaborazione con l'Associazione Italiana di Oncologia Medica (leggi e scarica). Strumento interattivo in due versioni, ...
Leggi tutto

24 Ottobre 2017

FDA Grants Priority Review to Frontline Cabozantinib in RCC

October 16, 2017 - The FDA has granted a priority review to a supplemental new drug application (sNDA) for cabozantinib for previously untreated patients with advanced renal cell carcinoma (RCC), according to Exelixis, the developer of the multikinase inhibitor. The sNDA ...
Leggi tutto

24 Ottobre 2017

NICE Rejects Treatments for Bladder and Thyroid Cancer

October 20, 2017 - The UK’s National Institute for Health and Care Excellence (NICE) has issued guidelines recommending against nivolumab for routine use in patients with previously-treated advanced urothelial carcinoma. The agency also recommended against lenvatinib ...
Leggi tutto

24 Ottobre 2017

Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial

Patients with colorectal cancer (CRC) receiving oxaliplatin (OXA) develop acute and chronic painful oxaliplatin-induced peripheral neuropathy (OXAIPN). Acute and chronic OXA-related neuropathies have different pathophysiological bases, but both lead to a common phenomenon: ...
Leggi tutto

24 Ottobre 2017

18 ottobre 2017 – Nuova versione di EudraVigilance: cosa cambia per il sistema italiano di FV a partire dal 22 novembre

23 Ottobre 2017

20 ottobre 2017 – Monitoraggio della Spesa Farmaceutica Nazionale e Regionale (gennaio / giugno 2017)

20 Ottobre 2017

FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma

October 18, 2017 - The U.S. Food and Drug Administration today approved axicabtagene ciloleucel, a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of ...
Leggi tutto

20 Ottobre 2017

Abiraterone Approaches EU Approval for Newly Diagnosed Hormone-Sensitive Prostate Cancer

October 16, 2017 - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the existing marketing authorization for abiraterone acetate to include use in combination with prednisone/prednisolone and androgen deprivation ...
Leggi tutto

20 Ottobre 2017

Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients

Primary cytoreduction, followed by chemotherapy, is a standard treatment of patients with epithelial ovarian cancer (EOC). However, the effectiveness of this treatment depend on various elements e.g. type of operation. It is accepted that optimal surgery correlates with ...
Leggi tutto

20 Ottobre 2017

Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses

The Iressa Mutation-Positive Multicentre Treatment Beyond ProgRESsion Study (IMPRESS) compared the continuation of gefitinib plus chemotherapy with placebo plus chemotherapy in patients with epidermal growth factor receptor (EGFR) mutation–positive advanced non–small-cell ...
Leggi tutto